Keep in mind
Connect the care choice to your health
As of September 2026, semaglutide products had different approved uses, so the reason for care helped determine which product was being discussed.
Bring the goal you want help with. Then ask the health professional to connect the choice to your own history.
A label describes groups of patients; the visit is where the health professional assesses you.
Beyond the name you found
Understand a weight measure if it comes up
BMI means body mass index, a measure using height and weight. Ask the health professional to explain what it adds to your assessment.
Adult weight studies of semaglutide (Wegovy) enrolled people with a BMI of 30 or above. People with a BMI of 27 or above could also join if they had a weight-related health problem.
Those rules for joining a study do not guarantee that a person qualifies for treatment or for insurance payment.
Those are BMI scores, not weights in pounds. Ask the health professional to work out your score from your height and weight, then explain which study group it matches.
Ask which product label and which payment rules apply to the plan being discussed.
Keep in mind
Ask why this choice fits
What in my health history makes this an option, and what might rule it out?
Make room for the explanation before discussing how soon care could begin.
Beyond the name you found
Plan for checking progress and for change
The checks called for in Wegovy’s label cover blood sugar in diabetes patients and regular measurements of resting heart rate.
It also calls for kidney checks when unwanted effects could cause fluid loss.
STEP 1 was the name of a weight-loss study in adults without diabetes.
Researchers later checked some people from that study after treatment stopped. Within the following year, roughly two-thirds of the earlier loss had been regained.
That trial does not decide your future plan. Discuss the follow-up plan for a medicine that does not suit you or becomes too costly to continue.
Endnotes
Notes for this chapter
- Semaglutide (Wegovy): who was studied and what needs checking
The label describes the study groups and the checks.
- Medicare program: eligibility rules
Payment programs can have rules beyond a product’s label.
- Weight trial: follow-up after treatment stopped
This is a trial finding, rather than a forecast for you.